Meridian Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.21M | Sell |
10,605
-177
| -2% | -$96.1K | 1.3% | 23 |
|
|
2025
Q4 | $6.25M | Buy |
10,782
+409
| +4% | +$231K | 1.55% | 20 |
|
|
2025
Q3 | $5.03M | Buy |
10,373
+207
| +2% | +$96.4K | 1.35% | 25 |
|
|
2025
Q2 | $4.75M | Buy |
10,166
+4,844
| +91% | +$2.03M | 1.3% | 27 |
|
|
2025
Q1 | $2.65M | Sell |
5,322
-26
| -0.5% | -$14.1K | 0.82% | 35 |
|
|
2024
Q4 | $2.78M | Sell |
5,348
-355
| -6% | -$195K | 0.73% | 34 |
|
|
2024
Q3 | $3.53M | Buy |
5,703
+93
| +2% | +$55.1K | 0.9% | 31 |
|
|
2024
Q2 | $3.1M | Sell |
5,610
-61
| -1% | -$34.9K | 0.85% | 33 |
|
|
2024
Q1 | $3.3M | Buy |
5,671
+86
| +2% | +$48.3K | 0.9% | 30 |
|
|
2023
Q4 | $3.08M | Sell |
5,585
-49
| -0.9% | -$23.7K | 0.87% | 30 |
|
|
2023
Q3 | $2.85M | Buy |
5,634
+23
| +0.4% | +$12.3K | 0.93% | 26 |
|
|
2023
Q2 | $2.93M | Sell |
5,611
-99
| -2% | -$53.4K | 0.92% | 29 |
|
|
2023
Q1 | $3.29M | Sell |
5,710
-169
| -3% | -$95.3K | 1.08% | 27 |
|
|
2022
Q4 | $3.24M | Buy |
5,879
+23
| +0.4% | +$12.2K | 1.18% | 25 |
|
|
2022
Q3 | $2.97M | Buy |
5,856
+152
| +3% | +$85.1K | 1.19% | 27 |
|
|
2022
Q2 | $3.1M | Sell |
5,704
-406
| -7% | -$223K | 1.2% | 25 |
|
|
2022
Q1 | $3.61M | Sell |
6,110
-68
| -1% | -$39.1K | 1.14% | 25 |
|
|
2021
Q4 | $4.12M | Buy |
6,178
+40
| +0.7% | +$25K | 1.19% | 25 |
|
|
2021
Q3 | $3.51M | Sell |
6,138
-187
| -3% | -$103K | 1.08% | 28 |
|
|
2021
Q2 | $3.19M | Sell |
6,325
-2,841
| -31% | -$1.34M | 0.94% | 34 |
|
|
2021
Q1 | $4.18M | Buy |
9,166
+121
| +1% | +$57.8K | 1.3% | 25 |
|
|
2020
Q4 | $4.21M | Sell |
9,045
-55
| -0.6% | -$25.8K | 1.35% | 24 |
|
|
2020
Q3 | $4.02M | Sell |
9,100
-68
| -0.7% | -$28.1K | 1.49% | 17 |
|
|
2020
Q2 | $3.32M | Sell |
9,168
-2,165
| -19% | -$726K | 1.36% | 20 |
|
|
2020
Q1 | $3.21M | Buy |
11,333
+58
| +0.5% | +$18.3K | 1.55% | 16 |
|
|
2019
Q4 | $3.66M | Sell |
11,275
-18
| -0.2% | -$5.46K | 1.47% | 18 |
|
|
2019
Q3 | $3.29M | Sell |
11,293
-4
| -0% | -$1.15K | 1.47% | 19 |
|
|
2019
Q2 | $3.32M | Buy |
11,297
+557
| +5% | +$153K | 1.47% | 19 |
|
|
2019
Q1 | $2.94M | Sell |
10,740
-20
| -0.2% | -$4.98K | 1.46% | 18 |
|
|
2018
Q4 | $2.41M | Hold |
10,760
| – | – | 1.23% | 22 |
|
|
2018
Q3 | $2.63M | Buy |
10,760
+15
| +0.1% | +$3.45K | 1.14% | 26 |
|
|
2018
Q2 | $2.23M | Buy |
10,745
+120
| +1% | +$25.5K | 1.03% | 30 |
|
|
2018
Q1 | $2.19M | Buy |
+10,625
| New | +$2.23M | 1.01% | 30 |
|
Other funds holding TMO
VCM
Meridian Management's TMO Position: Q1 2026 in Review
Meridian Management reduced its Thermo Fisher Scientific (TMO) stake by 1.6% in Q1 2026, selling an estimated $96.1K and leaving 10,605 shares worth $5.21M. The position accounts for 1.3% of the portfolio, ranked #23.
Meridian Management first reported a position in TMO in Q1 2018 and has held it in 33 quarters since. The position peaked at $6.25M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Meridian Management held 10,605 shares of Thermo Fisher Scientific worth $5.21M as of Q1 2026.
- Meridian Management sold 177 Thermo Fisher Scientific shares in Q1 2026, an estimated $96.1K.
- Thermo Fisher Scientific made up 1.3% of Meridian Management's portfolio in Q1 2026, its #23 holding.
- Meridian Management first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 33 quarters since.
- Meridian Management's Thermo Fisher Scientific position peaked at $6.25M in Q4 2025.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Meridian Management's 13F filing for Q1 2026, filed 5 May 2026.